Ford Smith Featured on Double Blind: Inside the Quest to Make “Plant-Based” MDMA

In a recent Double Blind article, Ultranative’s Ford Smith was featured for his pioneering efforts in the future of plant-based psychedelic medicine. The piece explores his efforts to sustainable, fair-trade supply chains and the role of natural sources in producing MDMA for therapeutic use.

As psychedelic-assisted therapy moves toward mainstream adoption, Ford’s vision, rooted in ethical sourcing and regenerative medicine, offers a compelling alternative to synthetic production. His work at Ultranative continues to push the boundaries of innovation, investment, and impact in the space.